In a 37-year-old patient with celiac disease who is taking tirzepatide and has abdominal pain and diarrhea, could the celiac disease be causing these symptoms?

Could Celiac Disease Be Causing These Symptoms?

Yes, celiac disease absolutely can cause abdominal pain and diarrhea in your patient, and this must be thoroughly evaluated before attributing symptoms solely to tirzepatide. 1, 2

Primary Gastrointestinal Manifestations of Celiac Disease

Celiac disease classically presents with the exact symptoms your patient is experiencing:

• Abdominal pain and diarrhea are among the most common gastrointestinal manifestations of celiac disease, along with bloating, flatulence, and weight loss 2, 3
• These symptoms occur due to gluten-induced impairment of the small intestinal mucosal surface and consequent malabsorption of nutrients 2
• The clinical presentation varies widely—some patients have full-blown gastrointestinal symptoms while others may be asymptomatic 3, 4

Critical Diagnostic Considerations

You must determine whether your patient is adherent to a gluten-free diet and whether their celiac disease is adequately controlled:

• Persistently positive anti-tissue transglutaminase (TG2-IgA) antibodies indicate ongoing intestinal injury and continued gluten exposure 5
• Even small amounts of inadvertent gluten from cross-contamination or hidden sources can keep antibody titers elevated and prevent complete intestinal recovery 5
• Follow-up serology should be checked at 6 months, 12 months after diagnosis, and annually thereafter 1, 5

Important Caveat About Serology

• Negative serology does NOT guarantee mucosal healing—the sensitivity of antibody assays for detecting low-level dietary transgressions is limited 5
• Patients with persistent or relapsing symptoms should undergo endoscopic biopsies to determine healing even when serology is negative 1

Evaluating Tirzepatide's Contribution

While investigating celiac disease control, consider tirzepatide's gastrointestinal effects:

• Gastrointestinal adverse events are the most commonly reported side effects of tirzepatide and are dose-dependent: 39% at 5mg, 46% at 10mg, and 49% at 15mg 6
• Nausea and diarrhea are the most frequent gastrointestinal complaints at any dose 6
• These effects can overlap with celiac disease symptoms, making differentiation challenging

Algorithmic Approach to This Patient

Step 1: Assess Gluten-Free Diet Adherence

• Conduct a thorough dietary assessment looking for obvious gluten contamination 5
• Investigate hidden sources of gluten and cross-contamination 5
• Review food labels, dining habits, and potential inadvertent exposures 4

Step 2: Check Celiac Serology

• Measure TG2-IgA antibodies 1, 5
• If persistently positive: this indicates ongoing intestinal damage and gluten exposure 5
• If negative: proceed to Step 3 as this does not rule out mucosal injury 1, 5

Step 3: Consider Endoscopic Evaluation

• Perform esophagogastroduodenoscopy with small bowel biopsies if symptoms persist without obvious explanation, regardless of serologic results 1
• This directly assesses mucosal healing and can identify ongoing celiac-related damage 1

Step 4: Evaluate Tirzepatide Timing

• Determine when symptoms began relative to tirzepatide initiation
• If symptoms started or worsened after starting tirzepatide, consider dose reduction or temporary discontinuation as a diagnostic trial
• Drug discontinuation due to adverse events occurs in 10% of patients on the 15mg dose 6

Common Pitfalls to Avoid

• Do not assume negative serology means the patient's celiac disease is well-controlled—biopsy may still show ongoing damage 1, 5
• Do not attribute all gastrointestinal symptoms to tirzepatide without verifying celiac disease control first—undiagnosed or poorly controlled celiac disease can have severe long-term consequences 2, 3
• Do not overlook hidden gluten sources including medications, supplements, and cross-contamination during food preparation 5, 4

Bottom Line

Both conditions can cause identical symptoms. Verify the original celiac disease diagnosis was accurate, confirm current gluten-free diet adherence, check celiac serology, and strongly consider repeat endoscopic biopsies given persistent symptoms 1, 5. Only after confirming adequate celiac disease control can you confidently attribute symptoms primarily to tirzepatide.